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Abstract 
A stable isotope dilution LC-MS/MS method is the method of choice for the selective 
quantitative determination of several folate species in clinical samples. By implementing an 
integrated approach to determine both the plasma and red blood cell (RBC) folate status, the 
use of consumables and time remains limited. 
Starting from a single 300 µl whole blood sample, the folate status in plasma and RBCs can 
be determined after separating plasma and RBCs and sequential washing of the latter with 
isotonic buffer, followed by reproducible lysis using an ammonium-based buffer. 
Acidification combines both liberation of protein bound folates and protein precipitation. 
Sample cleanup is performed using a 96-well reversed-phase solid-phase extraction 
procedure, similar for both plasma and RBC samples. Analyses are performed by UHPLC-
MS/MS. 
Method validation was successfully performed based on EMA-guidelines and encompassed 
selectivity, carry-over, linearity, accuracy, precision, recovery, matrix effect and stability. 
Plasma and RBC folates could be quantified in the range of 1 to 150 nmol/l and 5 to 1500 
nmol/l, respectively. 
This method allows for the determination of 6 folate monoglutamates in both plasma and 
RBCs. It can be used to determine short and long term folate status in both normal and 
severely deficient subjects in a single analytical sequence. 
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1. Introduction 
Folates, a group of essential water-soluble B-vitamins (B9), are key cofactors in both the 
methylation cycle and DNA-synthesis. Folate deficiency has been implicated in several health 
disorders, with a proven link between periconceptional folate deficiency and the prevalence of 
neural tube defects [1]. Other health issues such as increased cancer risk due to a disruption of 
DNA methylation and misincorporation of uracil may be related to folate deficiency [2]. Also, 
an impaired or halted methylation cycle causes neural damage through the reduced 
myelination of the nervous system [3] and leads to increased plasma homocysteine 
concentrations [4,5]. Following several decades of research it is evident that knowledge of 
nutrient status, including folate concentrations, is of paramount importance for the evaluation 
of individual health. 
Clinical folate status is traditionally determined in serum by a competitive folate binding 
protein (FBP) assay or a microbial assay. However, more recently developed liquid 
chromatographic tandem mass spectrometric (LC-MS/MS) methods allow to discriminate 
between different metabolically active folate species for which the microbial and ligand 
binding assays are not equally specific [6-8].  
For LC-MS/MS analysis of folates in plasma or serum, several methods have been published, 
differing in certain steps. Nelson et al. showed that affinity extraction with FBP led to lower 
detection limits, compared to reversed-phase solid-phase extraction (SPE) [9]. However, 
Hannisdal et al. omitted the purification step and simply used protein precipitation and 
evaporation as sample cleanup technique, yielding similar results [10]. Also, Garbis et al. 
showed that hydrophilic interaction liquid chromatography can be used to separate four 
different folate species [11]. Using an automated phenyl-based SPE system, a sensitive and 
high-throughput method for the measurement of serum folates was devised by Fazili et al. 
[12]. 
Lysis of whole blood samples for folate analysis is commonly performed using an L-ascorbic 
acid (AA) solution as a lysing agent [13-15]. However, this strategy was criticized due to 
differences in the assayable folate concentrations, attributable to differences in solution 
strength, which may lead to incomplete lysis, non-linear dilution curves and variable lysis 
times [16]. The addition of AA to whole blood lysates causes deoxygenation of hemoglobin 
due to the acidification of the sample. Since folates are trapped within the structure of 
oxyhemoglobin, deoxygenation is required for deconjugation [17]. Alternatively, lyophilized 
RBCs have also been used as a starting material to which an extraction buffer is added [18]. 
Since most LC-MS/MS procedures only measure folate monoglutamates, it is necessary to 
incubate the lysate at 37 °C for 2 to 12 hours to allow human γ-glutamylhydrolase (GGH), 
present in plasma, to deconjugate the folate polyglutamates present in the sample. Mostly heat 
inactivation is used to stop this reaction [13]. Samples can be purified using affinity extraction 
with FBP, followed by SPE to concentrate the sample [13]. However, most used is ion-
exchange or reversed-phase SPE without affinity extraction [18,19]. Mixed-mode sorbents 
can be used, though this necessitates an evaporation-dissolution step to remove the organic 
solvent from the sample [14]. 
Given the high amount of folates present in RBCs, it is difficult to obtain a blank matrix. A 
surrogate matrix, consisting of lyophilized egg white and sunflower oil in an isotonic sodium 
chloride solution, is sometimes used [18]. Another approach is to serially dilute samples with 
water in order to estimate the detection limits of the method [19]. In both approaches, the 
obtained results may not be a true reflection of actual method performance. A better approach, 
as applied by e.g. Kirsch et al., may be to use a matrix treated with activated charcoal to 
assess method performance, although it should be noted that this matrix also differs in many 
aspects from non-treated matrix [14]. 
To selectively quantify plasma, RBC free and RBC total folate, we developed a new LC-
MS/MS method, with the focus on the sample preparation steps. This method was set up as 
such, that most of the treatment steps, consumables and solvents were shared for both plasma 
and RBC analyses, thereby optimizing the workflow and augmenting sample throughput. 
Also, reproducible RBC lysis, an obstacle troubling previously published methods, was 
achieved using a lysis buffer specific for RBCs, while addition of dithiothreitol (DTT) assures 
the release of folates from hemoglobin. To assess method performance, a full validation was 
performed, based upon European Medicines Agency (EMA) guidelines, including selectivity, 
carry-over, linearity, accuracy, precision, recovery, matrix effects and stability in whole 
blood, prepared extracts and while being in the autosampler [20]. Additionally, certified 
reference materials for both plasma and RBCs were analyzed to assure interlaboratory 
accuracy.  
 
2. Materials and methods 
2.1 Reagents and materials 
The six folate monoglutamates studied are: tetrahydrofolate (THF), 5-methyltetrahydrofolate 
(5MeTHF), 5,10-methenyltetrahydrofolate (5,10CH
+
THF), 10-formylfolic acid (10FoFA), 5-
formyltetrahydrofolate (5FoTHF) and folic acid (FA). The folate reference standards were 
obtained from Schirck’s Laboratories (Jona, Switzerland), while the labeled internal standards 
(ISs), with a labeling yield higher than 98%, were obtained from Merck Eprova (Glattbrugg, 
Switzerland). At the pH values reached during sample preparation and analysis, the 
metabolically active 10-formyltetrahydrofolate (10FoTHF) is detected as 5,10CH
+
THF. Also, 
5,10-methylenetetrahydrofolate (5,10CH2THF) is unstable at acidic pH and is measured as 
THF [21, 22]. All calibrators and 
13
C5 labeled IS solutions were prepared in a final 
concentration of 200 nM in a 50mM sodium phosphate buffer, pH 7.5, containing 1% AA and 
0.5% DTT / methanol (50/50 v/v%). 
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THF were used as IS for their 
respective isotopologues. Stripped rat serum was obtained starting from non-sterile, non-
hemolysed rat serum, obtained from Harlan (Horst, The Netherlands), which was stirred on 
ice for 1 hour with 100 mg/ml of activated charcoal (Sigma-Aldrich, Diegem, Belgium) to 
remove endogenous folates. Following removal of the activated charcoal by centrifugation at 
4500 g for 15 minutes at 4 °C, the solution was filtered over a 0.45 µm syringe filter (GD/X 
CA 25/0.45, Whatman, GE Healthcare, Little Chalfont, UK), divided into aliquots and frozen 
at -80 °C. Acetonitrile (ACN) and methanol of LC-MS quality were purchased from Biosolve 
(Valkenswaard, The Netherlands). Formic acid, trisodium phosphate, AA and DTT were 
obtained from Sigma Aldrich. SPE was performed in a 96-well format with Bond Elut C18 
100 mg sorbent, purchased from Agilent (Palo Alto, CA, USA). Deionized water (H2O-MQ) 
was produced in house by means of a Synergy UV water-purification system from Millipore 
(Billerica, MA,USA). 
 
2.2 Preparation of stripped calibrator and QC-matrix 
EDTA-anticoagulated blood samples were obtained from healthy volunteers, 4 male and 2 
female, aged 25 to 37. To remove endogenous folates, plasma and RBC extracts were treated 
with activated charcoal as described for rat serum in paragraph 2.1. 
 
2.3 Sample preparation 
Folate analysis was performed starting from 300 µl EDTA-anticoagulated venous blood. 
Plasma extracts were prepared by adding 500 µl of phosphate buffered saline (PBS) to the 
whole blood sample. After centrifugation at 1000 g for 5 minutes at 4 °C, 500 µl of 
supernatant was withdrawn. To this aliquot 50 µl of a 1% AA, 0.5% DTT solution (containing 
all ISs in a final concentration of 3.0 nmol/l) was added to stabilize the folates. Following 15 
minutes of incubation at room temperature, the samples were either analyzed immediately or 
frozen at -80°C. To the remainder of the samples, which contain the RBCs, 1 ml of PBS at 
room temperature was added, followed by resuspension, centrifugation at 1000 g for 5 
minutes at 4 °C and removal of 1 ml supernatant. This washing procedure was repeated two 
more times. After the final removal of 1 ml supernatant, 800 µl of lysis buffer (168 mM 
NH4Cl; 10 mM KHCO3; 0.1 mM EDTA) was added [23]. Selective RBC lysis occurred 
during a 10-minute incubation at room temperature, after which cell residues were spun down 
by centrifugation at 2500 g for 10 minutes at 4 °C. One milliliter of supernatant was 
withdrawn and 100 µl of IS/AA/DTT solution was added. After incubation for 15 minutes at 
room temperature, these samples were analyzed further or frozen at -80°C. A flowchart 
describing the sample preparation procedure is shown in Supplementary Figure S1. 
 
2.4 Enzyme treatment and protein precipitation 
To measure the total folate content in RBCs, 100 µl of stripped rat serum was added to 500 µl 
of RBC lysate and incubated for 2 hours at 37 °C. This stripped rat serum serves as an 
exogenous source of GGH to deconjugate the folate polyglutamates present in RBC samples. 
The reaction was halted by addition of 300 µl of 10 vol% acetic acid in water. This 
acidification of the sample also liberates protein-bound folates and causes protein 
precipitation [24]. While no enzyme treatment is necessary to measure free monoglutamates 
in plasma and RBCs, these samples were also acidified by adding 250 µl of 10% acetic acid. 
The acidified samples were incubated for 20 minutes at 4 °C prior to centrifugation at 11 000 
g for 15 minutes at 4 °C. 
2.5 Sample cleanup 
SPE was performed using a Bond Elut 96-well plate containing 100 mg C18 sorbent per well. 
The sorbent was activated with 2 x 600 µl of methanol and conditioned with 2 x 600 µl of 
1.67 / 3.03 / 30.30 / 65 v/v/v% CH3COOH / 10% AA, 1% DTT-solution / PBS / H2O-MQ. 
Next, plasma and RBC samples were diluted with an equal volume of water of which 1 ml for 
plasma extracts and 800 µl for RBC extracts was loaded onto the sorbent. The sorbent was 
then washed with 2 x 600 µl of conditioning buffer prior to elution with 450 µl of elution 
buffer (7.5 / 92.5 v/v% ACN/ 50 mM trisodium phosphate with 1% AA and 0.1% DTT; pH= 
7.3). The SPE procedure is summarized in Supplementary Figure S1. 
 
2.6 LC-MS/MS analysis 
Samples were analyzed using a Waters Acquity UPLC
®
 system coupled to an ABSciex API 
4000
TM
 triple quadrupole mass spectrometer equipped with a TurboIonSpray
®
 probe. The 
autosampler was equipped with a sample loop of 10 µl and samples were kept at 4 °C prior to 
injection. After injection the needle was cleaned with 600 µl of 10/90 v/v% H2O-MQ/ACN 
followed by 800 µl of 90/10 v/v% H2O-MQ/ACN. Chromatographic separation was achieved 
using a mobile phase composed of H2O-MQ (A) and ACN (B), each containing 0.1% of 
formic acid, with a flow rate of 0.6 ml/min on a Waters HSS T3-column (150 mm x 2.1 mm; 
1.8 µm) held at 60 °C. The composition of the mobile phase starts with 100% solvent A and is 
kept constant for 1.6 minutes. Thereafter the amount of solvent B is increased to 10% in 1.2 
minutes and to 16% in another 0.7 minutes after which the column is cleaned for 1.5 minutes 
with 95% solvent B and equilibrated to initial solvent composition for 3 minutes. This 
amounts to a total time of approximately 9 minutes between injections. Mass spectrometric 
detection was performed in scheduled multiple-reaction monitoring mode. Electrospray 
ionization was used to ionize the analytes with the ion spray voltage set at 2500 V and a 
temperature of 600 °C. Nitrogen was used as curtain gas, gas 1 and gas 2, with respective 
pressure settings at 25, 75 and 90 psig, and as collision gas at setting 11. The interface heater 
was switched on. The transitions monitored per compound were the same as described before 
[25], settings can be found in Supplementary Table S1. 
 
2.7 Validation 
The developed method was validated based on the EMA guidelines for bioanalytical method 
validation [20]. Selectivity, carry-over, limit of detection (LOD) and lower limit of 
quantification (LLOQ), linearity, precision (including incurred sample reanalysis), accuracy, 
matrix effect, recovery and stability were evaluated. 
2.7.1 Selectivity and carry-over 
Selectivity was evaluated by analyzing plasma and RBC lysates from six individual donors (4 
male and 2 female), both with and without treatment with activated charcoal. Cross-
interferences were evaluated by adding the 6 folates and 4 labeled ISs individually to stripped 
matrix in a concentration of 100 nmol/l for plasma samples (150 nmol/l for 5FoTHF) and 300 
(THF and 5,10CH+THF), 500 (5MeTHF, FA and 10FoFA) or 750 nmol/l (5FoTHF) for RBC 
extracts. For the analytes, the acceptance criterion for the selectivity assessment was set at 
20% of the peak area corresponding to the LLOQ level, while for the labeled ISs only 5% was 
considered acceptable. Carry-over was evaluated by injecting blank samples after calibrators 
with identical concentrations and acceptance criteria as for the evaluation of selectivity. 
2.7.2 Linearity, accuracy and precision 
The actual LLOQ was verified as the concentration which could be measured with a %bias 
and relative standard deviation (RSD) below 20%. The LOD was calculated as one third of 
the LLOQ. Duplicate calibration curves of 7 calibrators and 1 zero sample for plasma or 9 
calibrators (8 for THF and 5,10CH
+
THF) and 1 zero sample for RBC were constructed on 4 
non-consecutive days to evaluate linearity. Homoscedasticity was evaluated by plotting the 
residuals versus the nominal values. The sum of the residual error was used to evaluate the 
need for a weighted model (1/x, 1/x², 1/y, 1/y², √x, ln(x), log(x)). For the selected model to be 
acceptable, back-calculated mean concentrations should be within 15% of the nominal value 
(20% at LLOQ-level). Accuracy and precision were evaluated using 4 QCs (LLOQ to 3/4 
upper limit of quantification (ULOQ), Table 1), prepared and analyzed on 4 non-consecutive 
days. A single-factor ANOVA was used to calculate inter- and intrabatch variability (%RSD). 
Accuracy (%bias) was calculated as the measured value divided by the nominal value. 
Acceptance criteria for %bias and %RSD are 15%, except at LLOQ level, where they are 20% 
[26]. An RBC sample of a healthy volunteer was analyzed in duplicate on 3 non-consecutive 
days to evaluate the precision of a sample requiring deconjugation of the folate 
polyglutamates. Also, the dilution integrity of RBC extracts exceeding the ULOQ was 
verified by two- or fourfold dilution of RBC matrix spiked at a concentration of 600 to 3000 
nmol/l with SPE elution buffer prior to UHPLC-MS/MS analysis (n=4).  
2.7.3 Recovery and Matrix effects 
Matrix effect and recovery were evaluated at 3 concentration levels (3LLOQ to 3/4ULOQ, 
Table 1) in matrix obtained from 6 individual sources according to Matuszewski et al. [27]. At 
the 3LLOQ concentration level, stripped matrix was used. To prepare the MID and 3/4ULOQ 
concentration levels, untreated matrix was used. The analytes were spiked either before (A) or 
after (B) the extraction and SPE procedure. Also, analytes were spiked in SPE elution buffer 
to obtain a sample free of matrix (C). Absolute recovery was calculated as the percent ratio of 
peak areas A over B, while absolute matrix effect was calculated as the percent ratio of the 
peak areas B over C. Relative recovery and matrix effect are expressed as %RSD of the 
absolute recovery and matrix effect values and should not exceed 15%. 
2.7.4 Stability 
The stability of folates in whole blood samples was verified by storing whole blood at 4 °C 
for 0, 1, 2, 7 and 10 days, while protected from light, before performing the entire sample 
preparation procedure in triplicate. Autosampler stability was assessed by reinjection of 
samples stored for 24 hours in the autosampler while concentrations were calculated based on 
fresh calibrators. Long term stability of plasma and RBC lysates at -80°C was evaluated by 
analysis of samples in duplo after 0, 1, 2 and 4 weeks including freshly prepared calibration 
curves. Also, the effect of up to three freeze-thaw cycles was evaluated by freezing and 
thawing the samples in cycles of 1 hour. Stability is acceptable if the concentration measured 
does not deviate more than 15% from that measured initially. 
2.7.5 Application 
The accuracy of the method was evaluated via the measurement of two certified reference 
materials, namely: Vitamin B12 and Serum Folate (03/178) and Folate in Whole Blood 
Haemolysate (95/528), both WHO International Standards issued by the National Institute for 
Biological Standards and Control (NIBSC). The reference material for serum has previously 
been measured by e.g. Fazili et al. [12].  
 
3. Results and discussion 
3.1 Method optimization 
3.1.1 Sample treatment 
The method starts from 300 µl of whole blood. Following removal of the plasma sample, the 
RBC pellet is washed to remove plasma residues. To evaluate the washing procedure of RBCs 
we monitored the removal of GGH activity by measuring the concentration of 5MeTHF 
monoglutamate in RBC lysates after 2 hours of incubation at 37 °C without addition of rat 
serum GGH. Whole blood lysate, sole plasma removal and 1 to 4 washing steps were 
evaluated. The amount of 5MeTHF monoglutamates remained stable after at least 2 washing 
steps, indicating that human GGH was sufficiently removed. One additional washing step was 
included to ensure reproducible removal of plasma proteins, plasma folates and other 
constituents. 
Given the need for complete and reproducible RBC lysis, several solvent compositions 
described in literature were evaluated. These were either based on the selective absorption of 
ammonia by RBCs (0.15 M NH4Cl, 10 mM NaHCO3, 10 mM EDTA at pH 7.4), hyper- (1% 
AA) or hypotonicity (deionized water) or susceptibility to ethanol or saponin [28-32]. The 
addition of 1% AA, ethanol or saponin resulted in incomplete lysis and would require at least 
one freeze-thaw cycle for full lysis. In contrast, the ammonia lysis buffer and deionized water 
led to full lysis of RBCs. The former was selected because it has been reported to selectively 
lyse RBCs, leaving other cells unaffected [29]. However, this buffer showed limited shelf life, 
with prolonged storage resulting in increased lysis times. Therefore, it was used within 
fourteen days after preparation and was stored at 4 °C. 
3.1.2 Folate deconjugation 
Since folates trapped within the quaternary structure of oxyhemoglobin are not accessible to 
GGH, deoxygenation of hemoglobin is necessary to measure the total amount of folates in the 
sample. While other methods rely on the Bohr effect (decrease of pH) to decrease oxygen 
binding affinity [17], in our method DTT was added to RBC extracts, which gently 
deoxygenates hemoglobin to produce a mixture of deoxy-, met- and sulfhemoglobin, leading 
to a release of folates [33]. 
To deconjugate the folate polyglutamates present in RBCs, the samples are incubated with 
stripped rat serum, which serves as a reliable source of the necessary GGH enzyme. Addition 
of 100 µl stripped rat serum to 500 µl of RBC lysate, containing AA, DTT and ISs, and 
incubation for 2 hours at 37 °C proved optimal to assure full deconjugation. However, the 
incubation of RBC extracts at 37 °C led to a minor conversion of THF to 5,10CH
+
THF. From 
literature it could be concluded that this reaction, which is catalyzed by a formate-activating 
enzyme (or formyltetrahydrofolate synthetase) present in RBCs, can be prevented by 
denaturing the enzyme at 55 °C for 5 minutes or by addition of NaCl to a concentration of 50 
mM [34]. Since the latter inhibited the deconjugation of folate polyglutamates, the heat 
treatment was preferred. 
3.1.3 Protein precipitation 
A significant part of folates is bound to FBP. These folates can be released by acidification to 
a pH below 5.5, which strongly diminishes the binding capacity of FBP [24]. Thus, 10% 
acetic acid was added as this combines protein precipitation and the liberation of protein-
bound folates. Moreover, this renders an additional treatment with protease unnecessary. 
3.1.4 Solid-phase extraction 
Since both reversed-phase and ion-exchange SPE [9,18,19] have been used for the 
determination of folates in plasma and RBC extracts, the retention behavior of 6 folate 
monoglutamates on various sorbent types was evaluated. Strong-anion exchange showed 
inferior retention of 5,10CH
+
THF, but gave less background noise. However, since 
5,10CH
+
THF was regularly detected in plasma and RBC samples, the superior recovery 
obtained using the reversed-phase sorbents was of greater importance. Comparable results 
were found with phenyl and C18 sorbents. The C18 sorbent was selected for further 
optimization. 
3.2 Method validation 
3.2.1 Selectivity and carry-over 
Method selectivity was evaluated using spiked stripped blood samples of 6 apparently healthy 
volunteers. Apart from a limited conversion of THF to 5,10CH
+
THF in RBC extracts, the MS 
signals for none of the folates exceeded 20% of the LLOQ of the others. A 5 minute treatment 
at 55 °C restricted the conversion of THF to 5,10CH
+
THF to on average 3.1% of the amount 
of THF present in the RBC sample. When the THF concentration exceeds 33 nmol/l, an 
apparent 5,10CH
+
THF concentration will be observed which is higher than 20% of the 
LLOQ. In non-stripped samples, no interfering peaks were observed that would hamper folate 
analysis, based on an evaluation of peak shape and baseline resolution. No unacceptable 
carry-over was observed in either plasma or RBCs for any of the folates analyzed 
(Supplementary Table S2).  
3.2.2 Linearity, accuracy and precision 
The data were heteroscedastic; a linear unweighted model was preferred for all folates in both 
matrices, since weighting provided little benefit based on the evaluation of the sum relative 
error. Also, the back-calculated concentrations of the calibrators fell within the acceptance 
criteria using this linear model. The LLOQ and ULOQ range from 1 to 1.5 and 100 to 150 
nmol/l, respectively, for plasma and from 5 to 7.5 and 300 to 1500 nmol/l, respectively, for 
RBCs (Table 1). 
In plasma the interbatch variation for 5FoTHF at the LLOQ level slightly exceeded the 20% 
acceptance criterion (21.3%), which may be improved using the commercially available 
13
C5-
5FoTHF as IS. All other accuracy and precision values fell within 15% bias resp. RSD (or 
20% at the LLOQ level) (Table 2).  
To assess the reproducibility of measurements in a true RBC extract, in which mainly folate 
polyglutamates are present, incurred samples were analyzed in duplicate during three different 
analytical runs. In these samples only 5MeTHF and 5,10CH
+
THF could be quantified, with a 
respective intrabatch precision (%RSD) of 7.5 and 9.6% and a respective interbatch precision 
(%RSD) of 7.7 and 9.6%, at a respective average concentration of 124 and 22.8 nmol/l. A 
two- or fourfold dilution of samples exceeding the ULOQ with SPE elution buffer proved 
possible, with bias and RSD below 15%. (Supplementary Table S3) 
To investigate whether the treatment of the matrix with activated charcoal, used to prepare 
calibrators, affected the calibration results, two calibration curves were compared. One was 
prepared in stripped matrix, the other in untreated matrix. As can be seen in Table 3, the slope 
of both the plasma and the RBC calibration curves deviated less than 7.3% and 6.8% between 
stripped and untreated matrix. Also, cross-calculated concentrations fell within the acceptance 
criteria, except for RBC folates at LLOQ level, which was likely due to the high background 
folate concentrations in untreated RBC samples. As such, the use of stripped matrix does not 
influence the analytical results. 
3.2.3 Recovery and Matrix effects 
Matrix effects and recoveries for both plasma and RBCs are shown in Table 4, both with and 
without compensation by the ISs. Overall, IS-compensated recoveries lay between 91.2 and 
107.5% for plasma and 84.8 and 117.2 for RBCs, while matrix effects -with a single 
exception for 5FoTHF- did not exceed 20%. Both 10FoFA and 5FoTHF showed slightly 
different recoveries and matrix effects than 
13
C5-FA, which is used as an IS for these 
compounds. Though some values for IS-compensated relative recovery and matrix effect 
exceeded the 15% acceptance criterion, none were larger than 20%. The relative recovery and 
matrix effect values without IS-compensation demonstrate the necessity of using labeled ISs 
to compensate for the variability between samples. 
3.2.4 Stability 
Folates present in the plasma fraction of whole blood proved stable for 24 hours, while the 
folates present in RBCs proved stable up to 10 days (Supplementary Figures S2 A and B). As 
observed by Hannisdal et al., the stability of plasma folates can be improved through the use 
of heparin or citrate instead of EDTA as anticoagulant.[35] Therefore, if sample stability is an 
issue, it is unlikely that the use of heparin as an alternative anticoagulant would negatively 
influence method performance. Long term storage of plasma samples at -80 °C was possible 
up to 4 weeks (Supplementary Figure S3 A). RBC folates showed a steady decrease upon 
storage at -80 °C, where after storage for 4 weeks a loss of approximately 20% was observed 
for all folates (Supplementary Figure S3 B). Processed samples were stable for at least 24 
hours in the refrigerated autosampler at 4 °C (Supplementary Table S4 A and B). Although 
samples with a low folate concentration were more susceptible to the effects of freeze-thaw 
cycles, up to three freeze-thaw cycles did not have an unacceptable effect on the folate levels 
measured in both plasma and RBC samples at higher concentration levels (Supplementary 
Tables S5 A and B). 
 
3.3 Application 
In the plasma certified reference material (NIBSC 03/178), analyzed in sevenfold, only 5-
MeTHF could be detected and quantified in a concentration of 11.1 nmol/l (SD: 0.233 
nmol/l). While this concentration is slightly higher than that reported by the NIBSC and by 
Fazili et al. [12] (resp. 13.8 and 7.8%), the total folate concentration measured is slightly 
lower than that reported by the NIBSC (8.3%). Also, Fazili et al. [12] measured higher total 
folate (15.9%), reporting on the presence of FA and MeFox (an oxidation product of 
5MeTHF) as well (Table 5). There is no real discrepancy between our results and those of 
Fazili et al. First, although the FA concentration reported by these authors is low, lying 
between the LOD and LLOQ of our method, we did not detect FA. We cannot exclude that 
slight differences in FA formation during sample processing may account for this. Second, 
MeFox was not included in our method given the lack of commercially available reference 
standards. Also, MeFox was not detected in samples using the mass transitions described for 
this compound. 
For RBCs, peak areas are back-calculated to the folate concentration in the reconstituted 
reference material. THF, 5MeTHF and 5,10CH
+
THF could be quantified in the reference 
material. Also FA and 10FoFA were present, with peak areas between the LOD and LLOQ, 
while no 5FoTHF was detected. The sum of the individual folates only exceeds the total folate 
measurement reference value set by the NIBSC by 6.0%. All values can be found in Table 5. 
The method was tested on blood samples obtained from 6 healthy volunteers (4 male and 2 
female) after overnight fasting. Results are depicted in Figure 1 and Supplementary Figure S4. 
The total plasma folate concentration ranged from 7.05 to 17.0 nmol/l. The main folate form 
was 5-MeTHF, minor folate forms exceeding the LLOQ were 10FoFA, THF and FA.  
In only four out of six subjects, RBC folate monoglutamate exceeded the LLOQ, 5MeTHF 
being the major folate species and THF being quantifiable in only 1 sample. Total folate 
concentrations in RBCs ranged from 222 to 504 nmol/l. Similarly to plasma, 5MeTHF is the 
major folate species in RBCs, while THF and 5,10CH
+
THF are present in minor amounts. 
FA, 10FoFA and 5FoTHF could also be quantified in some samples. Based on the total folate 
concentration and the concentration of folate monoglutamates, the degree of 
polyglutamylation of RBC folates was calculated, which appeared to be fairly constant in 
samples obtained from these volunteers, ranging from 96.9 to 98.4% (n=4).  
 
4. Conclusion 
Due to the similarity between the plasma and RBC analyses, these can be performed 
simultaneously, thus optimizing workload and sample throughput while minimizing the 
consumption of solvents and consumables.  
Starting from a single sample of 300 µl EDTA-anti-coagulated whole blood, the fully 
validated analytical method presented here allows to quantitatively determine 6 folate species 
in plasma and RBC extracts. The validation data showed linearity of the method from 1 to 150 
nmol/l for plasma samples and 5 to 1500 nmol/l for RBC samples, encompassing the 
clinically relevant ranges. Our method includes selective and reproducible ammonia-based 
RBC lysis, the addition of DTT to all solvents and acidic protein precipitation. This offers an 
advantage over previously published methods which may suffer from poor reproducibility due 
to incomplete lysis and uncontrolled protein binding [17]. In RBCs, both free folate 
monoglutamates and total folate (monoglutamates + polyglutamates) can be quantified. From 
this, the degree of polyglutamylation can be calculated. This may provide information on the 
efficacy of the FPGS enzyme responsible for the intracellular accumulation of folate 
polyglutamates. Since plasma GGH is removed prior to RBC lysis, the presence of different 
folate polyglutamates may be visualized using the chromatographic method developed by 
Wang et al. [36]. Our method can also be used to identify individuals with a polymorphism in 
the gene encoding the methylenetetrahydrofolate reductase enzyme. A significant difference 
in folate speciation has been observed in blood samples obtained from these individuals [37].  
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